Literatura académica sobre el tema "Antibody treatment"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Antibody treatment".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Antibody treatment"
Sasaki, Shigeru, Yasuhisa Shinomura y Kozo Imai. "Antibody treatment". Drug Delivery System 30, n.º 1 (2015): 16–24. http://dx.doi.org/10.2745/dds.30.16.
Texto completoJolobe, O. M. "Monoclonal antibody treatment". BMJ 340, apr01 2 (1 de abril de 2010): c1850. http://dx.doi.org/10.1136/bmj.c1850.
Texto completoLitzman, Jiří. "Treatment of antibody immunodeficiency". Vnitřní lékařství 65, n.º 2 (1 de febrero de 2019): 126–30. http://dx.doi.org/10.36290/vnl.2019.025.
Texto completoEspinoza, LR. "Antiphospholipid Antibody Syndrome: Treatment". Lupus 5, n.º 5 (octubre de 1996): 456–57. http://dx.doi.org/10.1177/096120339600500525.
Texto completoMehdi, Ali A., Imad Uthman y Munther Khamashta. "Treatment of antiphospholipid antibody syndrome". International Journal of Clinical Rheumatology 5, n.º 2 (abril de 2010): 241–54. http://dx.doi.org/10.2217/ijr.10.8.
Texto completoGibbons, W. "Antibody Treatment Joins AIDS Battle". Science News 139, n.º 4 (26 de enero de 1991): 55. http://dx.doi.org/10.2307/3975553.
Texto completoLiddle, Rachel. "Antibody treatment for ovarian cancer". Lancet Oncology 8, n.º 8 (agosto de 2007): 676. http://dx.doi.org/10.1016/s1470-2045(07)70229-2.
Texto completoVexler, Vladimir y Jacky Woo. "Antibody treatment of ulcerative colitis". Drug Discovery Today: Therapeutic Strategies 3, n.º 3 (septiembre de 2006): 353–60. http://dx.doi.org/10.1016/j.ddstr.2006.07.002.
Texto completoWahl, Denis y Veronique Regnault. "Treatment of Antiphospholipid Antibody Syndrome". JAMA 296, n.º 1 (5 de julio de 2006): 42. http://dx.doi.org/10.1001/jama.296.1.42.
Texto completoGardulf, Ann. "Immunoglobulin Treatment for Primary Antibody Deficiencies". BioDrugs 21, n.º 2 (2007): 105–16. http://dx.doi.org/10.2165/00063030-200721020-00005.
Texto completoTesis sobre el tema "Antibody treatment"
Alsughayyir, Jawaher. "CD49d-specific Single Domain Antibodies for the Treatment of Multiple Sclerosis". Thesis, Université d'Ottawa / University of Ottawa, 2012. http://hdl.handle.net/10393/23528.
Texto completoChen, Chao y 陳超. "Identification of a novel cancer therapeutic antibody against human epidermal growth factor receptor 2 (Her2) and antibody engineering for development of cancer therapeutics". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/196461.
Texto completopublished_or_final_version
Microbiology
Doctoral
Doctor of Philosophy
Schroeder, Krista Marie. "Disparities in Monoclonal Antibody Treatment of Elderly Metastatic Colorectal Cancer Patients". ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/1421.
Texto completoOdili, Joy Ifeyinewa. "Development of specific antibody fragments for the detection and treatment of melanoma". Thesis, University College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430128.
Texto completoAlberts, Justin Charles John. "Bispecific antibody mediated targeting cytotoxic lymphocytes for the treatment of colorectal carcinoma". Thesis, University College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248396.
Texto completoDouglass, Angela. "The use of an antibody in the diagnosis and treatment of liver fibrosis". Thesis, University of Aberdeen, 2009. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=131533.
Texto completoDI, CINTIO FEDERICA. "Nanoparticles anti-GPC1 for glioblastoma multiforme treatment". Doctoral thesis, Università degli Studi di Trieste, 2022. http://hdl.handle.net/11368/3015204.
Texto completoGlioblastoma multiforme (GBM) the most aggressive (WHO grade IV) diffuse glioma, is also by far the most frequent one. After standard treatment, the 2-year overall survival of GBM patients is approximately only 25%. Although numerous experimental drugs have been tested in clinical trials, GBM patients have not yet profited of curative treatments. To overcome the big limitations regarding GBM treatment, we address the challenge of developing a drug delivery system based on highly biocompatible chitosan nanobubbles (NBs) conjugated with an anti-glypican1 (GPC1) antibody loaded with docetaxel as chemotherapeutic agent. This drug delivery approach has been proposed to counter major challenges as overcoming the BBB, allowing the therapeutic release exclusively to tumor cells, and minimizing the possible side effects in cancer patients. The GPC1 proteoglycan has been chosen as useful target for drug delivering with NBs, therefore GPC1 expression was characterized in-vitro, being found expressed in GBM cell lines (e.g., T98G, U87-MG) but not found expressed in non-GBM cell line. Consistently, we assessed the localization of GPC1 protein expression on the cell surface and in the cytoplasm of GBM cell lines whereas it was lacked in the negative control cells. Of note, in primary tumor sections of these 10 GBM cases, GPC1 was found overexpressed whereas in normal tissues was found not expressed. To obtain a specific anti-GPC1 antibody recognizing the last 70 amino acid of GPC1 protein and therefore the cell-surface form of GPC1, mouse immunization has been performed. Hybridomas have produced three different anti-GPC1 specific clones (A, B, C). By using the B and C clones, GPC1 expression was detected in GBM cells at levels comparable to the levels obtained by using the commercially available antibody by the B and C clones. On the contrary, the A clone was not capable to recognize GPC1. Therefore, we purified the B and C clones to obtain specific anti-GPC1 monoclonal Abs. Moreover, C and B appeared to be more efficient than the a-GPC1c for detection of GPC1 expression levels. According to the results of antibody testing in GBM cell lines and negative control cell lines, the B clone was chosen to be conjugated to the NBs to develop the active drug delivery strategy. To select the drug to be loaded in the NBs, the killing capability of temozolomide (TMZ), paclitaxel (PTX) and docetaxel (DTX) was evaluated in GBM cells. DTX have the highest killing capability compared to PTX and TMZ. Therefore, we used DTX for the NBs loading encapsulation. The in-vitro characterization of NBs showed the average diameter of about 350 nm and a positive charge and spherical morphology. In-vitro analysis of the treatment of NBs in GBM cells, showed the localization of NBs conjugated with B antibody in cell cytoplasm around the nucleus. In contrast, a lower mean fluorescence intensity was observed for the cells treated with unconjugated NBs. For the in-vitro cytotoxic effect of NBs, NB loaded with DTX, NBs loaded with DTX and conjugated with B antibody, showed a killing capability correlated with the concentration in each evaluated point, with cell viable levels comparable to those of free DTX for some concentrations. Blank NBs, NB conjugated with Cy 5.5, and NB conjugated with B antibody were not toxic at all tested concentrations. In-vivo and ex-vivo test of the biodistribution of anti-GPC1 NBs in xenograft GBM mouse models, showed that the presence of the conjugation with the B antibody seems to be allow a major accumulation of the injected NBs in the tumor as well as a higher retention time at least until the last time point of 96 h of treatment. In conclusion, the proposed active drug delivery approach using anti-GPC1 conjugated NBs loaded with DTX could be useful for the treatment of GBM.
Arrowood, Michael James. "Cryptosporidium: Oocyst production and hybridoma generation for examining colostrum and monoclonal antibody roles in cryptosporidial infections". Diss., The University of Arizona, 1988. http://hdl.handle.net/10150/184335.
Texto completoLopez-Oliva, Santa Cruz Isabel. "Rheumatoid arthritis and periodontitis : antibody response, oral microbiome, cytokine profile and effect of periodontal treatment". Thesis, University of Birmingham, 2018. http://etheses.bham.ac.uk//id/eprint/8058/.
Texto completoLocker, Kathryn CS. "Molecular mechanisms underlying treatment of acute type 1 diabetes with an anti-TLR4/MD2 antibody". University of Cincinnati / OhioLINK, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1601993060493285.
Texto completoLibros sobre el tema "Antibody treatment"
K, Dessain Scott, ed. Human antibody therapeutics for viral disease. Berlin: Springer Verlag, 2008.
Buscar texto completo1960-, Grossbard Michael L., ed. Monoclonal antibody-based therapy of cancer. New York: Dekker, 1998.
Buscar texto completoA, Foon Kenneth y Morgan Alton C, eds. Monoclonal antibody therapy of human cancer. Boston: Nijhoff, 1985.
Buscar texto completoW, Baldwin R., Byers Vera S y Mann R. D. 1928-, eds. Monoclonal antibodies and immunoconjugates in cancer treatment. Carnforth: Parthenon Publishing, 1990.
Buscar texto completoCeriani, Roberto L., ed. Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2443-4.
Texto completoL, Ceriani Roberto y International Workshop on Breast Cancer Research (5th : 1992 : San Francisco, Calif.), eds. Antigen and antibody molecular engineering in breast cancer diagnosis and treatment. New York: Plenum Press, 1994.
Buscar texto completoE, Frankel Arthur, ed. Immunotoxins. Boston: Kluwer Academic Publishers, 1988.
Buscar texto completo1927-, Baldwin R. W., Byers Vera S y Mann Ronald D. 1928-, eds. Monoclonal antibodies and immunoconjugates. Carnforth, Lancs, UK: Parthenon Pub. Group, 1990.
Buscar texto completoG, Melton Roger y Knox Richard J, eds. Enzyme-prodrug strategies for cancer therapy. New York: Kluwer Academic/Plenum Publishers, 1999.
Buscar texto completoOehlrich, Marcus. Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene: A systematic review. Berlin: dissertation.de, 2003.
Buscar texto completoCapítulos de libros sobre el tema "Antibody treatment"
Acaia, Barbara, Federica Rossi y Cecilia Beatrice Chighizola. "Treatment of Pregnancy Complications". En Antiphospholipid Antibody Syndrome, 193–206. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-11044-8_16.
Texto completoBraham, Simon, Paolo Bucciarelli y Marco Moia. "Treatment of Thrombosis in Antiphospholipid Syndrome". En Antiphospholipid Antibody Syndrome, 185–92. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-11044-8_15.
Texto completoPress, Oliver W., Janet Eary, Frederick R. Appelbaum, Christopher C. Badger y Irwin D. Bernstein. "Radiolabeled antibody therapy of lymphoma". En Cancer Treatment and Research, 127–45. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-3084-8_9.
Texto completoSanz, Ana Rodríguez, Melissa Báez Martínez, Ángel Robles Marhuenda y Patricia Martínez-Sánchez. "Antiphospholipid Antibody Syndrome". En Stroke Revisited: Diagnosis and Treatment of Ischemic Stroke, 199–206. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-1424-6_18.
Texto completoOosterwijk, Egbert, Adrienne Brouwers, OTTO C. Boerman, Steven M. Larson, Lloyd J. Old, Peter Mulders y Chaitanya R. Divgi. "Monoclonal Antibody Therapy of Kidney Cancer". En Cancer Treatment and Research, 199–212. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4615-0451-1_12.
Texto completoWhelan, Glenn J. "Monoclonal Antibodies in the Treatment of Asthma". En Antibody-Mediated Drug Delivery Systems, 457–72. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118229019.ch22.
Texto completoBhattacharya-Chatterjee, Malaya y Kenneth A. Foon. "Anti-idiotype antibody vaccine therapies of cancer". En Cancer Treatment and Research, 51–68. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-6189-7_4.
Texto completoVahdat, Linda T. y Nancy Chan. "The Antibody-Drug Conjugate Glembatumumab Vedotin (CDX-011) and Its Use in Treatment of Breast Cancer". En Antibody-Drug Conjugates, 225–32. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13081-1_13.
Texto completoDeng, Rong y Joseph P. Balthasar. "Immune Complex Therapies for Treatment of Immune Thrombocytopenia". En Development of Antibody-Based Therapeutics, 391–404. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5955-3_17.
Texto completoKumar, Dhruv, Neelam Sharma-Walia, Sonia Kapoor y Simran Tandon. "Antibody-Targeted Nanoparticles for Cancer Treatment". En NanoBioMedicine, 35–65. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-32-9898-9_3.
Texto completoActas de conferencias sobre el tema "Antibody treatment"
Song, Muran. "The application of monoclonal antibody immunotherapy in cancer treatment". En International Conference on Biological Engineering and Medical Science (ICBIOMed2022), editado por Gary Royle y Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669347.
Texto completoPrudent, James R., David Marshall, John Murphy, Chad Hall y Scott Harried. "Abstract A125: Antibody targeted steroids for the treatment of cancer". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-a125.
Texto completoHerbert, Jenny y Timothy Mitchell. "Development of an antibody therapy for the treatment of pneumonia". En ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2623.
Texto completoXu, Minglu. "Progress and perspectives of antibody-drug conjugates in cancer treatment". En International Conference on Biological Engineering and Medical Science (ICBIOMed2022), editado por Gary Royle y Steven M. Lipkin. SPIE, 2023. http://dx.doi.org/10.1117/12.2669936.
Texto completoWillis, Jace A., Vsevolod Cheburkanov, Giulia Kassab, Vanderlei S. Bagnato y Vladislav V. Yakovlev. "MHV-1 in vivo viral load reduction via antibody-conjugated photodynamic inactivation". En Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021, editado por Tianhong Dai, Mei X. Wu y Jürgen Popp. SPIE, 2021. http://dx.doi.org/10.1117/12.2577893.
Texto completoParapia, L., A. Minford y J. B. Hamilton. "MONOCLONAL PURIFIED FACTOR VIII:C (MONOCLATE) TREATMENT IN A PREVIOUSLY UNTREATED HAEMOPHILIA". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644846.
Texto completoIshiguro, Takahiro, Yasuko Kinoshita, Masamichi Sugimoto, Yoko Miyazaki, Atsuhiko Kato, Kiyotaka Nakano, Hirotake Takai et al. "Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-2426.
Texto completoGiffin, Michael J., Ed K. Lobenhofer, Keegan Cooke, Tobias Raum, Jennitte Stevens, Pedro J. Beltran, Angela Coxon y Paul E. Hughes. "Abstract 3632: BiTE®antibody constructs for the treatment of SCLC". En Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-3632.
Texto completoSchmittnaegel, Martina, Eike Hoffmann, Olaf Mundigl, Gerhard Niederfellner, Klaus Bosslet, Pablo Umana, Victor Levitsky, Christian Klein y Hendrik Knoetgen. "Abstract B69: Novel MHC class I antibody fusions for cancer treatment." En Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-b69.
Texto completoNilsson, I. M., E. Berntorp y O. Zettervall. "TOLERANCE INDUCTION IN HIGH-RESPONDING HEMOPHILIACS WITH F VIII ANTIBODIES BY MEANS OF COMBINED TREATMENT WITH IgG, CYCLOPHOSPHAMIDE AND F VIII". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644717.
Texto completoInformes sobre el tema "Antibody treatment"
Sholler, Giselle. Marrow-Derived Antibody Library for Treatment of Neuroblastoma. Fort Belvoir, VA: Defense Technical Information Center, septiembre de 2013. http://dx.doi.org/10.21236/ada593124.
Texto completoBasu, Sayani. Monoclonal Antibody Therapy: A New Hope in Cancer Treatment. Natur Library, noviembre de 2020. http://dx.doi.org/10.47496/nl.blog.14.
Texto completoWu, Xin. The efficacy and safety of anti-CD20 antibody treatments in relapsing multiple sclerosis: a systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junio de 2022. http://dx.doi.org/10.37766/inplasy2022.6.0075.
Texto completoLiu, Miao, Hongan Wang, Jing Lu, Zhiyue Zhu, Chaoqun Song, Ye Tian, Xinzhi Chen et al. Vitamin D supplementation in the treatment of Myasthenia Gravis A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, septiembre de 2022. http://dx.doi.org/10.37766/inplasy2022.9.0129.
Texto completoBray, Elizabeth, Zvi Lerner y Alexander Poljakoff-Mayber. The Role of Phytohormones in the Response of Plants to Salinity Stress. United States Department of Agriculture, septiembre de 1994. http://dx.doi.org/10.32747/1994.7613007.bard.
Texto completoSpiegel, Yitzhak, Michael McClure, Itzhak Kahane y B. M. Zuckerman. Characterization of the Phytophagous Nematode Surface Coat to Provide New Strategies for Biocontrol. United States Department of Agriculture, noviembre de 1995. http://dx.doi.org/10.32747/1995.7613015.bard.
Texto completoSchwartz, Bertha, Vaclav Vetvicka, Ofer Danai y Yitzhak Hadar. Increasing the value of mushrooms as functional foods: induction of alpha and beta glucan content via novel cultivation methods. United States Department of Agriculture, enero de 2015. http://dx.doi.org/10.32747/2015.7600033.bard.
Texto completoCahaner, Avigdor, Susan J. Lamont, E. Dan Heller y Jossi Hillel. Molecular Genetic Dissection of Complex Immunocompetence Traits in Broilers. United States Department of Agriculture, agosto de 2003. http://dx.doi.org/10.32747/2003.7586461.bard.
Texto completo